Plus Therapeutics Inc (PSTV)
NASDAQ:PSTV

Plus Therapeutics (PSTV) Technical Analysis

538 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
6Neutral
5Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Plus Therapeutics Inc’s (PSTV) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting Plus Therapeutics Inc is a Sell.
Plus Therapeutics Inc’s (PSTV) 20-Day exponential moving average is 1.77, while Plus Therapeutics Inc’s (PSTV) share price is $1.87, making it a Buy.
Plus Therapeutics Inc’s (PSTV) 50-Day exponential moving average is 1.84, while Plus Therapeutics Inc’s (PSTV) share price is $1.87, making it a Buy.

Plus Therapeutics (PSTV) Pivot Points

Jul 29, 2024, 09:06 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.65
1.69
1.74
1.78
1.83
1.87
1.92
Fibonacci
1.69
1.72
1.74
1.78
1.81
1.83
1.87
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Plus Therapeutics (PSTV) Moving Averages

Jul 29, 2024, 09:06 AM
Period
Simple
Exponential
MA5
1.78Buy
1.80Buy
MA10
1.78Buy
1.78Buy
MA20
1.70Buy
1.77Buy
MA50
1.94Sell
1.84Buy
MA100
1.89Sell
1.88Sell
MA200
1.84Buy
1.88Sell
Plus Therapeutics Inc’s (PSTV) 10-Day exponential moving average is 1.78, while Plus Therapeutics Inc’s (PSTV) share price is $1.87, making it a Buy.
Plus Therapeutics Inc’s (PSTV) 100-Day exponential moving average is 1.88, while Plus Therapeutics Inc’s (PSTV) share price is $1.87, making it a Sell.
Plus Therapeutics Inc’s (PSTV) stock price is $1.87 and Plus Therapeutics Inc’s (PSTV) 50-day simple moving average is 1.94, creating a Sell signal.
Plus Therapeutics Inc’s (PSTV) stock price is $1.87 and Plus Therapeutics Inc’s (PSTV) 100-day simple moving average is 1.89, creating a Sell signal.
Plus Therapeutics Inc’s (PSTV) stock price is $1.87 and Plus Therapeutics Inc’s (PSTV) 200-day simple moving average is 1.84, creating a Buy signal.

Plus Therapeutics (PSTV) Technical Indicators

Jul 29, 2024, 09:06 AM
Name
Value
Implied Action
RSI (14)
55.25
Neutral
STOCH (9,6)
41.48
Neutral
STOCHRSI (14)
60.70
Neutral
MACD (12,26)
-0.01
Sell
ADX (14)
23.25
Neutral
Williams %R
-29.85
Buy
CCI (14)
82.48
Neutral
ATR (14)
0.17
-
Ultimate Oscillator
49.06
Neutral
ROC
24.67
Buy
Plus Therapeutics Inc’s (PSTV) Relative Strength Index (RSI) is 55.25, creating a Neutral signal.
Plus Therapeutics Inc’s (PSTV) Trend Strength Indicator (ADX) is 23.25, creating a Neutral signal.
Plus Therapeutics Inc’s (PSTV) Commodity Channel Index (CCI) is 82.48, creating a Neutral signal.
Plus Therapeutics Inc’s (PSTV) Price Rate of Change (ROC) is 24.67, creating a Buy signal.

FAQ

Is PSTV a Buy, Hold, or Sell?
Based on PSTV’s technical indicators, PSTV is a Buy.
    What is PSTV’s RSI (14)?
    PSTV’s RSI (14) is 55.25, which suggests PSTV is a Neutral.
      What is PSTV’s MACD?
      PSTV’s MACD is -0.01, which suggests PSTV is a Sell.
        What is PSTV’s 5-day moving average?
        PSTV’s 5-day moving average is 1.78, which suggests PSTV is a Buy.
          What is PSTV’s 20-day moving average?
          PSTV 20-day moving average is 1.70, which suggests PSTV is a Buy.
            What is PSTV’s 50-day moving average?
            PSTV’s 50-day moving average is 1.94, which suggests PSTV is a Sell.
              What is PSTV’s 200-day moving average?
              PSTV’s 200-day moving average is 1.84, which suggests PSTV is a Buy.
                What is PSTV’s Williams % R (14)?
                PSTV’s Williams % R (14) is -29.85, which suggests PSTV is a Buy.
                  What is PSTV’s CCI (14)?
                  PSTV’s CCI (14) is 82.48, which suggests PSTV is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis